PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection

Do Young Kim, Yong Han Paik, Sang Hoon Ahn, Young Jun Youn, Jong Won Choi, Ja Kyung Kim, Kwan Sik Lee, Chae Yoon Chon, Kwang Hyub Han

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)

Abstract

Objectives: The aim of this study is to assess the usefulness of prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) in monitoring of recurrent hepatocellular carcinoma (HCC) after curative resection. Methods: From April 2001 to March 2004, a total of 245 patients with histologically proven HCC and 267 non-HCC patients were recruited. Serial follow-up measurements of both alpha-fetoprotein (AFP) and PIVKA-II were performed in 27 patients who had recurrent HCC after resection. Results: In the initial HCC diagnosis, the sensitivity of AFP and PIVKA-II was 48.6% (119/245) and 75.1% (184/245), respectively, at the cutoff of 20 ng/ml for AFP and 40 mAU/ml for PIVKA-II (p < 0.01). The specificity was 81.3% (217/267) and 94.8% (253/267), respectively. When AFP and PIVKA-II were combined, the sensitivity and specificity was 83.3% (204/245) and 77.2% (206/267), respectively. In 27 patients developing recurrent HCC after curative surgical resection, the sensitivity of AFP and PIVKA-II was 40.7% (11/27) and 74.1% (20/27), respectively. Several fluctuating patterns of AFP and PIVKA-II were observed from initial diagnosis to recurrence. Conclusion: Our data suggest that PIVKA-II is a useful tumor marker for HCC, complementary to AFP. Serial measurements of both markers after resection might be helpful for early diagnosis of tumor recurrence.

Original languageEnglish
Pages (from-to)52-57
Number of pages6
JournalOncology
Volume72
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2007 Dec

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection'. Together they form a unique fingerprint.

Cite this